Home
About
FAQ
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Rocha Lima, Caio Max
One or more keywords matched the following items that are connected to
Rocha Lima, Caio Max
Item Type
Name
Academic Article
Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies.
Academic Article
Docetaxel followed by gemcitabine and irinotecan in solid tumors.
Concept
Deoxycytidine
Academic Article
New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways.
Academic Article
Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.
Academic Article
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Academic Article
Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer.
Academic Article
Novel advances in pancreatic cancer treatment.
Academic Article
Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.
Academic Article
Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancer.
Academic Article
Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.
Academic Article
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.
Academic Article
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.
Academic Article
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.
Academic Article
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.
Academic Article
Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity.
Academic Article
Irinotecan and gemcitabine in patients with solid tumors: phase I trial.
Academic Article
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
Academic Article
Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.
Academic Article
Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.
Academic Article
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere.
Academic Article
Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer.
Academic Article
New directions in the management of advanced pancreatic cancer: a review.
Academic Article
Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell lines.
Academic Article
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.
Academic Article
Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.
Academic Article
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
Academic Article
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.
Academic Article
Docetaxel in the management of advanced pancreatic cancer.
Search Criteria
Deoxycytidine